Literature DB >> 30676271

Duplex RNAs and ss-siRNAs Block RNA Foci Associated with Fuchs' Endothelial Corneal Dystrophy.

Jiaxin Hu1, Xiulong Shen1, Frank Rigo2, Thahza P Prakash2, V Vinod Mootha3,4, David R Corey1.   

Abstract

Fuchs' endothelial corneal dystrophy (FECD) leads to vision loss and is one of the most common inherited eye diseases. Corneal transplants are the only curative treatment available, and there is a major unmet need for treatments that are less invasive and independent of donor tissue. Most cases of FECD are associated with an expanded CUG repeat within the intronic region of TCF4 and the mutant RNA has been implicated as the cause of the disease. We previously presented preliminary data suggesting that single-stranded antisense oligonucleotides (ASOs) can inhibit CUG RNA foci in patient-derived cells and tissue. We now show that duplex RNAs and single-stranded silencing RNAs (ss-siRNAs) reduce the number of cells with foci and the number of foci per cells. Potencies are similar to those that are achieved with chemically modified ASOs designed to block foci. These data widen the potential for synthetic nucleic acids to be used to treat a widely prevalent and debilitating disease.

Entities:  

Keywords:  Fuchs' dystrophy; RNAi; ophthalmology; siRNA; ss-siRNA

Year:  2019        PMID: 30676271      PMCID: PMC6461152          DOI: 10.1089/nat.2018.0764

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  33 in total

1.  Asymmetry in the assembly of the RNAi enzyme complex.

Authors:  Dianne S Schwarz; György Hutvágner; Tingting Du; Zuoshang Xu; Neil Aronin; Phillip D Zamore
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

2.  Descemet's stripping endothelial keratoplasty five-year graft survival and endothelial cell loss.

Authors:  Marianne O Price; Kelly M Fairchild; David A Price; Francis W Price
Journal:  Ophthalmology       Date:  2010-10-29       Impact factor: 12.079

3.  Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.

Authors:  Jiaxin Hu; Jing Liu; David R Corey
Journal:  Chem Biol       Date:  2010-11-24

4.  Single-stranded microRNA mimics.

Authors:  Guillaume Chorn; Molly Klein-McDowell; Lihong Zhao; Matthew A Saunders; W Michael Flanagan; Aarron T Willingham; Lee P Lim
Journal:  RNA       Date:  2012-08-21       Impact factor: 4.942

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Preclinical evaluation of a phosphorothioate oligonucleotide in the retina of rhesus monkey.

Authors:  Wei-Yong Shen; Kerryn L Garrett; Chang-Guan Wang; Kun Zhang; Zhi-Zhong Ma; Ian J Constable; P Elizabeth Rakoczy
Journal:  Lab Invest       Date:  2002-02       Impact factor: 5.662

Review 7.  Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.

Authors:  Elias Fattal; Amélie Bochot
Journal:  Adv Drug Deliv Rev       Date:  2006-09-15       Impact factor: 15.470

Review 8.  Fomivirsen: clinical pharmacology and potential drug interactions.

Authors:  Richard S Geary; Scott P Henry; Lisa R Grillone
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex.

Authors:  Yanli Wang; Stefan Juranek; Haitao Li; Gang Sheng; Thomas Tuschl; Dinshaw J Patel
Journal:  Nature       Date:  2008-12-18       Impact factor: 49.962

10.  Short antisense oligonucleotides with novel 2'-4' conformationaly restricted nucleoside analogues show improved potency without increased toxicity in animals.

Authors:  Punit P Seth; Andrew Siwkowski; Charles R Allerson; Guillermo Vasquez; Sam Lee; Thazha P Prakash; Edward V Wancewicz; Donna Witchell; Eric E Swayze
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

View more
  4 in total

1.  Delivery of Antisense Oligonucleotides to the Cornea.

Authors:  Viet Q Chau; Jiaxin Hu; Xin Gong; John D Hulleman; Rafael L Ufret-Vincenty; Frank Rigo; Thahza P Prakash; David R Corey; V Vinod Mootha
Journal:  Nucleic Acid Ther       Date:  2020-03-23       Impact factor: 5.486

2.  Optimization in Chemical Modification of Single-Stranded siRNA Encapsulated by Neutral Cytidinyl/Cationic Lipids.

Authors:  Zheng Li; Xixian Wang; Xinyang Zhou; Jie Wang; Zhu Guan; Zhenjun Yang
Journal:  Front Chem       Date:  2022-03-07       Impact factor: 5.221

3.  Trinucleotide Repeat-Targeting dCas9 as a Therapeutic Strategy for Fuchs' Endothelial Corneal Dystrophy.

Authors:  Ziye Rong; Xin Gong; John D Hulleman; David R Corey; V Vinod Mootha
Journal:  Transl Vis Sci Technol       Date:  2020-08-31       Impact factor: 3.283

Review 4.  TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat-associated disease.

Authors:  Michael P Fautsch; Eric D Wieben; Keith H Baratz; Nihar Bhattacharyya; Amanda N Sadan; Nathaniel J Hafford-Tear; Stephen J Tuft; Alice E Davidson
Journal:  Prog Retin Eye Res       Date:  2020-07-28       Impact factor: 21.198

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.